BioCentury
ARTICLE | Clinical News

Apo2L/TRAIL: Completed Phase II enrollment

January 26, 2009 8:00 AM UTC

Last quarter, the partners completed enrollment of 213 patients in a 5-arm, open-label Phase II trial evaluating chemotherapy (carboplatin and paclitaxel) alone, chemotherapy plus 8 mg/kg AMG 951, che...